Tokushima, Japan

Hideaki Kuroda

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Osaka, JP (2016 - 2017)
  • Tokushima, JP (2007 - 2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Innovations of Hideaki Kuroda

Introduction

Hideaki Kuroda is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental disorders. With a total of 15 patents to his name, Kuroda's work has garnered attention for its innovative approaches and potential impact on mental health treatments.

Latest Patents

One of Kuroda's latest patents involves piperazine-substituted benzothiophenes for the treatment of mental disorders. This invention provides a heterocyclic compound represented by a specific general formula. The compound is noted for its wide treatment spectrum for mental disorders, including central nervous system disorders, while also boasting no side effects and high safety.

Career Highlights

Kuroda is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is characterized by a commitment to improving mental health treatments through innovative chemical compounds.

Collaborations

Kuroda has collaborated with notable colleagues such as Shin Miyamura and Hiroshi Yamashita, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Hideaki Kuroda's contributions to the field of pharmaceuticals, particularly in mental health treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect a dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…